Badran Abu Zher Layaly, Weil Merav, Kassem Eias, Elias Nael, Levine Myron M, Muhsen Khitam
Sackler Faculty of Medicine, Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University Ramat Aviv, Tel Aviv, Israel.
Central Virology Laboratory, Ministry of Health, Tel Hashomer, Israel.
Front Med (Lausanne). 2022 Jan 20;8:797719. doi: 10.3389/fmed.2021.797719. eCollection 2021.
To examine the association between seroprevalence and serum pepsinogens (PGs) as markers of gastric inflammation), with high neutralizing antibody titers to poliovirus type 1 and 3 vaccine strains among children age 3-4 years, subsequent to sub-clinical infection acquired during a wild-type poliovirus type 1 outbreak in Israel.
A serosurvey was conducted among 336 children aged 5-17 years who were vaccinated with both inactivated polio vaccine and oral polio vaccines. serum IgG antibodies and PG concentrations were measured using ELISA. Neutralizing antibodies to poliovirus vaccine strains were measured and children with a titer ≥1:8 were considered immune. High-level immunity was defined as having a serum NA titer >1:2048. Propensity score inverse weighting was used to account for confounders.
Neutralizing antibodies titers ≥1:8 to poliovirus type 1 and 3 vaccine strains were found in 99.4 and 98.2% of the children, respectively. An inverse association was found between seropositivity accompanied by PGI:PGII ratio ≤6.5 (marker of gastric inflammation) and high-level immunity to poliovirus type 1: OR 0.39 (95% CI 0.68-0.91), = 0.027. The association between seropositivity of CagA virulent phenotype and polio high immunity was not significant. The association between seropositivity and high neutralizing antibodies to type 3 poliovirus was of low magnitude and not significant.
seroprevalence accompanied by evidence of gastric inflammation was inversely correlated with high titers of neutralizing antibodies to poliovirus in children from a population with near universal polio immunity.
在以色列1型野生脊灰病毒疫情期间亚临床感染后,研究3至4岁儿童中脊髓灰质炎1型和3型疫苗株中和抗体滴度高的情况下,血清阳性率与作为胃炎症标志物的血清胃蛋白酶原(PGs)之间的关联。
对336名5至17岁同时接种了灭活脊髓灰质炎疫苗和口服脊髓灰质炎疫苗的儿童进行了血清学调查。使用酶联免疫吸附测定法测量血清IgG抗体和PG浓度。测量脊髓灰质炎疫苗株的中和抗体,滴度≥1:8的儿童被视为免疫。高免疫水平定义为血清中和抗体滴度>1:2048。采用倾向得分逆加权法来处理混杂因素。
分别在99.4%和98.2%的儿童中发现了脊髓灰质炎1型和3型疫苗株的中和抗体滴度≥1:8。在伴有PGI:PGII比值≤6.5(胃炎症标志物)的血清阳性与脊髓灰质炎1型高免疫水平之间发现了负相关:比值比为0.39(95%置信区间0.68 - 0.91),P = 0.027。CagA毒力表型血清阳性与脊髓灰质炎高免疫之间的关联不显著。血清阳性与3型脊髓灰质炎病毒高中和抗体之间的关联程度较低且不显著。
在几乎普遍具有脊髓灰质炎免疫力的人群中,伴有胃炎症证据的血清阳性率与儿童脊髓灰质炎中和抗体高滴度呈负相关。